CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudru, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudru, V.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 2384-2390, October 2005
© 2005 American Association for Cancer Research

Melanocortin-1 Receptor (MC1R) Gene Variants and Dysplastic Nevi Modify Penetrance of CDKN2A Mutations in French Melanoma-Prone Pedigrees

Valérie Chaudru1, Karine Laud2, Marie-Françoise Avril2, Annie Minière2, Agnès Chompret2, Brigitte Bressac-de Paillerets2, Florence Demenais1 and The French Familial Melanoma Study Group

1 Institut National de la Santé et Recherche Médicale et Université d'Evry, Evry, France and 2 Institut Gustave Roussy, Villejuif, France

Requests for reprints: Valérie Chaudru, Institut National de la Sante et de la Recherche Medicale, Université d'Evry, EMI 0006, Tour Evry 2, 523 Place des Terrasses de l'Agora, 91034 Evry, France. Phone: 33-1-6087-3820; Fax: 33-1-6087-3848. E-mail: chaudru{at}evry.inserm.fr

Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Penetrance of CDKN2A gene was found to be significantly influenced by host factors (nevus phenotypes and sunburn) on one hand and by variants of MC1R gene (RHC variants consistently associated with red hair and fair skin) on the other hand. Our goal was to examine the joint effects of MC1R variants and other potential risk factors [total nevi, dysplastic nevi, pigmentary traits (skin, hair and eye color), skin reactions to sunlight, and degree of sun exposure] on CDKN2A penetrance. Clinical, genetic, and covariate data were recorded in 20 French melanoma-prone families with cosegregating CDKN2A mutations. Analysis of the cotransmission of melanoma and CDKN2A mutations was conducted by likelihood-based methods using the regressive logistic models, which can account for a variation of disease risk with age and can include the aforementioned risk factors as covariates. RHC variants, considered either alone or in the presence of pigmentation and nevus phenotypes, were found to increase significantly CDKN2A penetrance. Multivariate analysis, using a stepwise selection procedure, showed significant effects of two factors on melanoma risk in CDKN2A mutations carriers: RHC variants [odds ratio of hazard function (OR), 2.21; P = 0.03] and dysplastic nevi (OR, 2.93; P < 0.01). Such results may have important consequences to improve the prediction of melanoma risk in families.




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. A. Kanetsky, T. R. Rebbeck, A. J. Hummer, S. Panossian, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. A. Culver, et al.
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Cancer Res., September 15, 2006; 66(18): 9330 - 9337.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
L. Naldi, G. Randi, A. Di Landro, C. La Vecchia, and Oncology Study Group of the Italian Group for Epid
Red hairs, number of nevi, and risk of cutaneous malignant melanoma: results from a case-control study in Italy.
Arch Dermatol, July 1, 2006; 142(7): 935 - 936.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.